Skip to content
PresyoGamot
Menu

Drospirenone + Ethinylestradiol in the Philippines

Quick answer

There is no DOH reference price for drospirenone + ethinylestradiol; FDA Philippines lists 11 registered drospirenone + ethinylestradiol products (checked 2026-11-05): 11 under 11 brand names. It is a prescription (Rx) medicine. No unbranded generic is registered, so ask for the cheapest brand with the same generic name and strength.

FDA-registered: 11 products11 brandsPrescription (Rx)

Strengths

Drospirenone + Ethinylestradiol by strength

Drospirenone + Ethinylestradiol is listed here in 1 strength; none has an FDA-registered product at that exact strength.

Drospirenone + Ethinylestradiol by strength
StrengthFDA products
Drospirenone + Ethinylestradiol 3 mg + 0.03 mgnot registered

Sources: FDA Philippines registry (2026-11-05), DOH DPRI June 2024.

About drospirenone + ethinylestradiol

Used for

This is a combined birth control pill with drospirenone, a progestin, and ethinylestradiol, an estrogen (spelled ethinyl estradiol in the US). The US FDA label lists three uses for women who can get pregnant:

  • preventing pregnancy
  • easing symptoms of premenstrual dysphoric disorder (PMDD), a severe mood disorder before periods
  • treating moderate acne from age 14

The label follows a pack of 24 hormone tablets plus 4 inactive ones. Packs with 0.03 mg ethinylestradiol carry their own leaflet and schedule.

How it works

The pill mainly stops the ovaries from releasing an egg. Drospirenone also has anti-androgen effects.

How to take it and usual dose

Take one tablet by mouth at the same time every day. You can start on the first day of your period or on the first Sunday after it starts. If you start later than day 1, use a non-hormonal back-up method for the first 7 days. Take a missed pill as soon as you remember. Your doctor decides the dose.

Do not use if

  • you are over 35 and smoke
  • you have kidney problems or adrenal insufficiency
  • you have or had blood clots, stroke or heart disease
  • you have uncontrolled high blood pressure
  • you have migraine with nerve symptoms, or any migraine after age 35
  • you have unexplained vaginal bleeding
  • you have breast cancer, liver tumors or liver disease
  • you take hepatitis C medicines with ombitasvir, paritaprevir/ritonavir

Common side effects

The US label carries a boxed warning that smoking raises the risk of heart attack and stroke, especially after age 35. Common effects are headache, irregular bleeding, nausea, breast tenderness and mood changes. Pills with drospirenone may carry a higher risk of blood clots than some other pills. Stop and see a doctor at once if a blood clot occurs or your skin or eyes turn yellow.

Source: US FDA label (DailyMed), 2026-01-29. A summary of the official label, not medical advice: your doctor or pharmacist knows your case.

Registered products

Registered drospirenone + ethinylestradiol products

FDA Philippines lists 11 registrations under 11 brand names.

Registered drospirenone + ethinylestradiol products
BrandStrength and formClassManufacturerReg.
Dronis3 mg/20 mcg Film-Coated TabletRxSun Pharmaceutical Industries Ltd. (India)1
Drospill3 mg/30 mcg Film-Coated TabletRxSun Pharmaceutical Industries Ltd. (India)1
Erin3mg/30 mcg Film-Coated TabletRxSun Pharmaceutical Industries Ltd. (India)1
Ermina3mg/20 mcg Film-Coated TabletRxSun Pharmaceutical Industries Ltd. (India)1
Liza3 mg/30 mcg Film-Coated TabletRxLaboratorios Leon Farma, S.A. (Spain)1
Lizelle3 mg / 20 mcg Film-Coated TabletRxLaboratorios Leon Farma S.A. (Spain)1
Lizonya3 mg/20 mcg Film-Coated TabletRxLaboratorios Leon Farma, S.A. (Spain)1
Yanci 203mg/20mcg TabletRxMylan Laboratories Ltd. (India)1
Show 3 more brands

Registered drospirenone + ethinylestradiol products, continued

Registered drospirenone + ethinylestradiol products, continued
BrandStrength and formClassManufacturerReg.
Yanci-303mg / 30mcg TabletRxMylan Laboratories Ltd. (India)1
Yasmin3 mg/30 mcg Film-Coated TabletRxBayer Weimar GmbH Und Co. KG (Germany)1
Yaz3 mg/ 20 mcg Film-Coated TabletRxBayer Weimar GmbH und Co. KG (Germany)1

Source: FDA Philippines product registry, checked 2026-11-05. Look up any registration number at verification.fda.gov.ph.

Official leaflets

The package insert (PI) and patient leaflet (PIL) filed with FDA Philippines. Doses, side effects and warnings are there, written by the maker and approved by FDA.

Paying less for drospirenone + ethinylestradiol

  • Ask for the generic

    Prescriptions are written in generic names, and the pharmacist must tell you every brand of that generic and its price. How it works

  • Senior or PWD card

    20% off plus no VAT on your own medicines, with ID and prescription. What to bring

Questions people ask

Do I need a prescription for drospirenone + ethinylestradiol in the Philippines?

FDA Philippines classifies drospirenone + ethinylestradiol as a prescription (Rx) medicine. A pharmacist may dispense it only against a valid prescription (Pharmacy Act, RA 10918).

Is there a generic drospirenone + ethinylestradiol registered in the Philippines?

FDA Philippines lists 11 registered drospirenone + ethinylestradiol products (checked 2026-11-05): 11 under 11 brand names. There is no unbranded generic in the registry; ask for the cheapest brand with the same generic name and strength.

Where can I buy drospirenone + ethinylestradiol legally?

From an FDA-licensed drugstore or botika; the licence to operate (LTO) should be displayed in the store. Bring your prescription. Check that the box carries a DR- registration number, and be careful with online sellers that are not licensed pharmacies.

Is drospirenone with ethinylestradiol over the counter in the Philippines?

No. FDA Philippines lists all registered products, the 3 mg/20 mcg and 3 mg/30 mcg film-coated tablets, as prescription (Rx) drugs.

Does drospirenone with ethinylestradiol help acne?

The US label lists moderate acne from age 14 as a use, but only for women who also want the pill for birth control.

Data: FDA Philippines registry (checked 2026-11-05), DOH Drug Price Reference Index (June 2024). Sources and method.